Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Eva Ružić-Sabljić & Tjaša Cerar. (2017) Progress in the molecular diagnosis of Lyme disease. Expert Review of Molecular Diagnostics 17:1, pages 19-30.
Read now
Read now
Daniel J Cameron, Lorraine B Johnson & Elizabeth L Maloney. (2014) Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Review of Anti-infective Therapy 12:9, pages 1103-1135.
Read now
Read now
Paul M Lantos. (2011) Chronic Lyme disease: the controversies and the science. Expert Review of Anti-infective Therapy 9:7, pages 787-797.
Read now
Read now
Alje P van Dam. (2011) Molecular diagnosis of Borrelia bacteria for the diagnosis of Lyme disease. Expert Opinion on Medical Diagnostics 5:2, pages 135-149.
Read now
Read now
Eva Sapi, Navroop Kaur, Samuel Anyanwu, David F Luecke, Akshita Datar, Seema Patel, Michael Rossi & Raphael B Stricker. (2011) Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infection and Drug Resistance 4, pages 97-113.
Read now
Read now
Raphael B Stricker & Lorraine Johnson. (2011) Lyme disease: the next decade. Infection and Drug Resistance 4, pages 1-9.
Read now
Read now
Raphael B Stricker, Andrew Lautin & Joseph J Burrascano. (2005) Lyme disease: point/counterpoint. Expert Review of Anti-infective Therapy 3:2, pages 155-165.
Read now
Read now
Raphael B Stricker & Andrew Lautin. (2003) The Lyme Wars: time to listen. Expert Opinion on Investigational Drugs 12:10, pages 1609-1614.
Read now
Read now
Alje P van Dam. (2001) Recent advances in the diagnosis of Lyme disease. Expert Review of Molecular Diagnostics 1:4, pages 413-427.
Read now
Read now
Articles from other publishers (72)
Samuel M. Shor & Sunjya K. Schweig. (2023) The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses. Microorganisms 11:7, pages 1759.
Crossref
Crossref
Y. L. Verschoor, A. Vrijlandt, R. Spijker, R. M. van Hest, H. ter Hofstede, K. van Kempen, A. J. Henningsson & J. W. Hovius. (2022)
Persistent Borrelia burgdorferi
Sensu Lato
Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models
. Clinical Microbiology Reviews 35:4.
Crossref
Crossref
Charles Farber, Rohini Morey, Mark Krimmer, Dmitry Kurouski & Artem S. Rogovskyy. (2021) Exploring a possibility of using Raman spectroscopy for detection of Lyme disease. Journal of Biophotonics 14:5.
Crossref
Crossref
John Lambert & Anne Cruikshank. 2021. Postural Tachycardia Syndrome. Postural Tachycardia Syndrome
193
196
.
Richard I. Horowitz & Phyllis R. Freeman. (2020) Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review. Antibiotics 9:11, pages 725.
Crossref
Crossref
Alexia Bernard, Pascal Seve, Amro Abukhashabh, Chantal Roure-Sobas, Andre Boibieux, Philippe Denis, Christiane Broussolle, Thibaud Mathis & Laurent Kodjikian. (2019) Lyme-associated uveitis: Clinical spectrum and review of literature. European Journal of Ophthalmology 30:5, pages 874-885.
Crossref
Crossref
Mark Obrenovich, Hayden Jaworski, Tara Tadimalla, Adil Mistry, Lorraine Sykes, George Perry & Robert Bonomo. (2020) The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases. Microorganisms 8:5, pages 784.
Crossref
Crossref
Jie Feng, Jacob Leone, Sunjya Schweig & Ying Zhang. (2020) Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi. Frontiers in Medicine 7.
Crossref
Crossref
Yurij Ionov & Artem S. Rogovskyy. (2020) Comparison of motif-based and whole-unique-sequence-based analyses of phage display library datasets generated by biopanning of anti-Borrelia burgdorferi immune sera. PLOS ONE 15:1, pages e0226378.
Crossref
Crossref
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
273
326
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
235
270
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
222
234
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
187
221
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
158
186
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
99
157
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
65
98
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
27
64
.
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies
1
25
.
Samuel Shor, Christine Green, Beatrice Szantyr, Steven Phillips, Kenneth Liegner, Joseph BurrascanoJr.Jr., Robert Bransfield & Elizabeth L. Maloney. (2019) Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group. Antibiotics 8:4, pages 269.
Crossref
Crossref
Natalie Rudenko, Maryna Golovchenko, Katerina Kybicova & Marie Vancova. (2019) Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters. Parasites & Vectors 12:1.
Crossref
Crossref
Cozette Moysa, Ross Murtagh & John S. Lambert. (2019) Potential Persistent Borrelia Infection and Response to Antibiotic Therapy; a Clinical Case Study and Review of Recent Literature. Antibiotics 8:4, pages 223.
Crossref
Crossref
Emir Hodzic, Denise M. Imai & Edlin Escobar. (2019)
Generality of Post-Antimicrobial Treatment Persistence of
Borrelia burgdorferi
Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains
. Infection and Immunity 87:10.
Crossref
Crossref
Artem S. Rogovskyy, Salvador Eugenio C. Caoili, Yurij Ionov, Helen Piontkivska, Pavel Skums, Viachaslau Tsyvina, Alex Zelikovsky & Suryakant D. Waghela. (2019) Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits. Infection and Immunity 87:8.
Crossref
Crossref
Maliha Batool, Andrew E. Hillhouse, Yurij Ionov, Kelli J. Kochan, Fatemeh Mohebbi, George Stoica, David W. Threadgill, Alex Zelikovsky, Suryakant D. Waghela, Dominique J. Wiener & Artem S. Rogovskyy. (2019)
New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium’s Functional
vlsE
Antigenic Variation System
. Infection and Immunity 87:7.
Crossref
Crossref
Justin Shemenski. (2019) Cimetidine as a novel adjunctive treatment for early stage Lyme disease. Medical Hypotheses 128, pages 94-100.
Crossref
Crossref
Marianne Middelveen, Eva Sapi, Jennie Burke, Katherine Filush, Agustin Franco, Melissa Fesler & Raphael Stricker. (2018) Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease. Healthcare 6:2, pages 33.
Crossref
Crossref
Marcus Davidsson. (2018) The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic. Healthcare 6:1, pages 16.
Crossref
Crossref
Elizabeth L. Maloney. (2016) Controversies in Persistent (Chronic) Lyme Disease. Journal of Infusion Nursing 39:6, pages 369-375.
Crossref
Crossref
Ruben Magni, Benjamin H. Espina, Ketul Shah, Benjamin Lepene, Christine Mayuga, Temple A. Douglas, Virginia Espina, Sally Rucker, Ross Dunlap, Emanuel F. III Petricoin, Mary Frekko Kilavos, Donald M. Poretz, Gilbert R. Irwin, Samuel M. Shor, Lance A. Liotta & Alessandra Luchini. (2015) Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis. Journal of Translational Medicine 13:1.
Crossref
Crossref
Kevin Alby & Gerald A. Capraro. (2015) Alternatives to Serologic Testing for Diagnosis of Lyme Disease. Clinics in Laboratory Medicine 35:4, pages 815-825.
Crossref
Crossref
Adam DyerGemma BrownLenka StejskalPeter R. LaityRichard J. Bingham. (2015) The Borrelia afzelii outer membrane protein BAPKO_0422 binds human factor-H and is predicted to form a membrane-spanning β-barrel. Bioscience Reports 35:4.
Crossref
Crossref
Jana Hercogová. 2015. European Handbook of Dermatological Treatments. European Handbook of Dermatological Treatments
561
566
.
Liesbeth Borgermans, Geert Goderis, Jan Vandevoorde & Dirk Devroey. (2014) Relevance of Chronic Lyme Disease to Family Medicine as a Complex Multidimensional Chronic Disease Construct: A Systematic Review. International Journal of Family Medicine 2014, pages 1-10.
Crossref
Crossref
Merit E Cudkowicz, Sarah Titus, Marianne Kearney, Hong Yu, Alexander Sherman, David Schoenfeld, Douglas Hayden, Amy Shui, Benjamin Brooks, Robin Conwit, Donna Felsenstein, David J Greenblatt, Myles Keroack, John T Kissel, Robert Miller, Jeffrey Rosenfeld, Jeffrey D Rothstein, Ericka Simpson, Nina Tolkoff-Rubin, Lorne Zinman & Jeremy M Shefner. (2014) Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. The Lancet Neurology 13:11, pages 1083-1091.
Crossref
Crossref
Emir Hodzic, Denise Imai, Sunlian Feng & Stephen W. Barthold. (2014) Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice. PLoS ONE 9:1, pages e86907.
Crossref
Crossref
Simon W Dubrey, Ajay Bhatia, Sarah Woodham & Wojtek Rakowicz. (2014) Lyme disease in the United Kingdom. Postgraduate Medical Journal 90:1059, pages 33-42.
Crossref
Crossref
James D. Berry, Jeremy M. Shefner, Robin Conwit, David Schoenfeld, Myles Keroack, Donna Felsenstein, Lisa Krivickas, William S. David, Francine Vriesendorp, Alan Pestronk, James B. Caress, Jonathan Katz, Ericka Simpson, Jeffrey Rosenfeld, Robert Pascuzzi, Jonathan Glass, Kourosh Rezania, Jeffrey D. Rothstein, David J. Greenblatt & Merit E. Cudkowicz. (2013) Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis. PLoS ONE 8:4, pages e61177.
Crossref
Crossref
Allison K. DeLong, Barbara Blossom, Elizabeth L. Maloney & Steven E. Phillips. (2012) Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials. Contemporary Clinical Trials 33:6, pages 1132-1142.
Crossref
Crossref
J. Szanyi, Z. Kubová, J. Kremláček, J. Langrová, F. Vít, M. Kuba, J. Szanyi & S. Plíšek. (2012) Pattern and Motion-Related Visual-Evoked Potentials in Neuroborreliosis. Journal of Clinical Neurophysiology 29:2, pages 174-180.
Crossref
Crossref
John D. Scott, John F. Anderson & Lance A. Durden. (2012) Widespread Dispersal of Borrelia burgdorferi?Infected Ticks Collected from Songbirds Across Canada. Journal of Parasitology 98:1, pages 49-59.
Crossref
Crossref
Gary P. Wormser & Guiqing Wang. 2011. Lyme Borreliosis in Europe and North America. Lyme Borreliosis in Europe and North America
159
183
.
Marika Nordberg, Pia Forsberg, Anna Johansson, Dag Nyman, Christian Jansson, Jan Ernerudh & Christina Ekerfelt. (2011) Cytotoxic mechanisms may play a role in the local immune response in the central nervous system in neuroborreliosis. Journal of Neuroimmunology 232:1-2, pages 186-193.
Crossref
Crossref
Aleksandar Milovanovic, J. Milovanovic, Sonja Obrenovic, Andjela Milovanovic, P. Simonovic, D. Cemerikic, Z. Tacevic, Ivana Petronic, M. Grajic, Divna Kekus & M. Popevic. (2011) Lyme neuroborreliosis. Acta veterinaria 61:1, pages 89-98.
Crossref
Crossref
Raphael B. Stricker & Lorraine Johnson. (2010)
The Lyme disease chronicles, continued:
Chronic Lyme disease: in defense of the patient enterprise
. The FASEB Journal 24:12, pages 4632-4633.
Crossref
Crossref
Stephen W. Barthold, Emir Hodzic, Denise M. Imai, Sunlian Feng, Xiaohua Yang & Benjamin J. Luft. (2010)
Ineffectiveness of Tigecycline against Persistent
Borrelia burgdorferi
. Antimicrobial Agents and Chemotherapy 54:2, pages 643-651.
Crossref
Crossref
Janet L.H. Sperling & Felix A.H. Sperling. (2012) Lyme borreliosis in Canada: biological diversity and diagnostic complexity from an entomological perspective. The Canadian Entomologist 141:6, pages 521-549.
Crossref
Crossref
D. Hulínská, J. Votýpka, D. Vaňousová, J. Hercogová, V. Hulínský, H. Dřevová, Z. Kurzová & L. Uherková. (2009) Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans. Folia Microbiologica 54:3, pages 246-256.
Crossref
Crossref
Øystein Brorson. (2009) Borrelia burgdorferi – en unik bakterie. Tidsskrift for Den norske legeforening 129:20, pages 2114-2117.
Crossref
Crossref
Raphael B StrickerLorraine Johnson. (2008) Chronic Lyme disease and the ‘Axis of Evil’. Future Microbiology 3:6, pages 621-624.
Crossref
Crossref
Iolanda Santino, Francesca Berlutti, Fabrizio Pantanella, Rosa Sessa & Massimo Del Piano. (2008) Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis. FEMS Microbiology Letters 283:1, pages 30-35.
Crossref
Crossref
Emir Hodzic, Sunlian Feng, Kevin Holden, Kimberly J. Freet & Stephen W. Barthold. (2008)
Persistence of
Borrelia burgdorferi
following Antibiotic Treatment in Mice
. Antimicrobial Agents and Chemotherapy 52:5, pages 1728-1736.
Crossref
Crossref
B. A. FallonJ. G. KeilpK. M. CorberaE. PetkovaC. B. BrittonE. DwyerI. SlavovJ. ChengJ. DobkinD. R. NelsonH. A. Sackeim. (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:13, pages 992-1003.
Crossref
Crossref
C Ekerfelt, M Andersson, A Olausson, S Bergström & P Hultman. (2007)
Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of
Borrelia burgdorferi
in C3H/HeN mice
. Clinical and Experimental Immunology 150:1, pages 189-197.
Crossref
Crossref
R. B. Stricker. (2007) Counterpoint: Long-Term Antibiotic Therapy Improves Persistent Symptoms Associated with Lyme Disease. Clinical Infectious Diseases 45:2, pages 149-157.
Crossref
Crossref
Y. Hansmann. (2007) Le traitement des phases secondaires et tertiaires de la borréliose de Lyme. Médecine et Maladies Infectieuses 37:7-8, pages 479-486.
Crossref
Crossref
Volker von Baehr, Christa Liebenthal, Brita Gaida, Frank-Peter Schmidt, R?diger von Baehr & Hans-Dieter Volk. (2007) Untersuchungen zur diagnostischen Wertigkeit des Lymphozytentransformationstestes bei Patienten mit Borreliose / Evaluation of the diagnostic significance of the lymphocyte proliferation test in patients with Lyme borreliosis. LaboratoriumsMedizin 31:3, pages 149-158.
Crossref
Crossref
Kristina Nilsson Ekdahl, Anna J. Henningsson, Kerstin Sandholm, Pia Forsberg, Jan Ernerudh & Christina Ekerfelt. 2007. Current Topics in Innate Immunity. Current Topics in Innate Immunity
198
213
.
Klaus-Peter Hunfeld & Volker Brade. (2006) Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: What we know, what we don't know, and what we need to know. Wiener klinische Wochenschrift 118:21-22, pages 659-668.
Crossref
Crossref
Klaus-Peter Hunfeld, Eva Ru?i?-Sablji?Douglas E. Norris, Peter Kraiczy & Franc Strle. (2006) Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance. International Journal of Medical Microbiology 296, pages 233-241.
Crossref
Crossref
Joel Spinhirne. (2006) Evaluation of Tests for Lyme Disease. Journal of Clinical Microbiology 44:4, pages 1616-1617.
Crossref
Crossref
Raphael B. Stricker, Andrew Lautin & Joseph J. Burrascano. (2006) Lyme Disease: The Quest for Magic Bullets. Chemotherapy 52:2, pages 53-59.
Crossref
Crossref
David C. Owen. (2006) Is Lyme disease always poly microbial? ? The jigsaw hypothesis. Medical Hypotheses 67:4, pages 860-864.
Crossref
Crossref
Maria E. Aguero-Rosenfeld, Guiqing Wang, Ira Schwartz & Gary P. Wormser. (2005) Diagnosis of Lyme Borreliosis. Clinical Microbiology Reviews 18:3, pages 484-509.
Crossref
Crossref
Ulrich R Hengge, Andrea Tannapfel, Steven K Tyring, Raimund Erbel, Gabriele Arendt & Thomas Ruzicka. (2003) Lyme borreliosis. The Lancet Infectious Diseases 3:8, pages 489-500.
Crossref
Crossref
Raphael B. Stricker & Steven E. Phillips. (2003) Lyme disease without erythema migrans: cause for concern?. The American Journal of Medicine 115:1, pages 72-73.
Crossref
Crossref
J. Hercogova. 2003. European Handbook of Dermatological Treatments. European Handbook of Dermatological Treatments
304
308
.
Guiqing Wang. (2002)
Direct Detection Methods for Lyme
Borrelia
, Including the Use of Quantitative Assays
. Vector-Borne and Zoonotic Diseases 2:4, pages 223-231.
Crossref
Crossref
Jana Hercogova. (2008) Lyme borreliosis. International Journal of Dermatology 40:9, pages 547-550.
Crossref
Crossref
M. Schwaiger, O. Péter & P. Cassinotti. (2001) Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay. Clinical Microbiology and Infection 7:9, pages 461-469.
Crossref
Crossref
Jana Hercogova & Iva Brzonova. (2001) Lyme disease in central Europe. Current Opinion in Infectious Diseases 14:2, pages 133-137.
Crossref
Crossref
J. Stephen Dumler. (2012) Molecular Diagnosis of Lyme Disease: Review and Meta-analysis. Molecular Diagnosis 6:1, pages 1-11.
Crossref
Crossref
Diego Cadavid, Tim O'Neill, Henry Schaefer & Andrew R Pachner. (2000) Localization of Borrelia Burgdorferi in the Nervous System and Other Organs in a Nonhuman Primate Model of Lyme Disease. Laboratory Investigation 80:7, pages 1043-1054.
Crossref
Crossref